Allison Bratzel
Stock Analyst at Piper Sandler
(4.87)
# 344
Out of 5,028 analysts
265
Total ratings
55.2%
Success rate
33.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Allison Bratzel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding | Reiterated: Buy | $75 | $46.81 | +60.22% | 15 | Sep 25, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $56 | $20.43 | +174.11% | 6 | Sep 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $88 → $90 | $57.18 | +57.40% | 9 | Sep 1, 2026 | |
| AKBA Akebia Therapeutics | Reiterated: Buy | $4 | $0.865 | +362.43% | 18 | Aug 17, 2026 | |
| ALXO ALX Oncology Holdings | Reiterated: Buy | $4 | $1.22 | +227.87% | 7 | Aug 17, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $16 → $15 | $3.34 | +349.10% | 9 | Aug 17, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,075 → $1,215 | $919.21 | +32.18% | 34 | Aug 17, 2026 | |
| BHVN Biohaven | Reiterated: Buy | $30 | $12.87 | +133.10% | 7 | Aug 17, 2026 | |
| CDXS Codexis | Reiterated: Buy | $9 → $8 | $1.36 | +488.24% | 12 | Aug 17, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $52 → $55 | $31.02 | +77.30% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.5215 | +91.75% | 10 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.07 | +194.84% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $130 | $115.30 | +12.75% | 13 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $94 | $43.54 | +115.89% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $10.80 | +177.91% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $15.22 | +346.78% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $49 | $47.15 | +3.92% | 10 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 → $68 | $56.93 | +19.44% | 21 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $13.74 | -12.66% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $13.07 | +7.12% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $175 | $92.88 | +88.42% | 13 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $4 | $1.94 | +106.19% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.5 | $0.0002 | +249,900.00% | 5 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $35.72 | n/a | 6 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $6.85 | n/a | 6 | Mar 14, 2024 |
Scholar Rock Holding
Sep 25, 2026
Reiterated: Buy
Price Target: $75
Current: $46.81
Upside: +60.22%
Tyra Biosciences
Sep 8, 2026
Reiterated: Buy
Price Target: $56
Current: $20.43
Upside: +174.11%
BioMarin Pharmaceutical
Sep 1, 2026
Reiterated: Buy
Price Target: $88 → $90
Current: $57.18
Upside: +57.40%
Akebia Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $0.865
Upside: +362.43%
ALX Oncology Holdings
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $1.22
Upside: +227.87%
Ardelyx
Aug 17, 2026
Reiterated: Buy
Price Target: $16 → $15
Current: $3.34
Upside: +349.10%
argenx SE
Aug 17, 2026
Reiterated: Buy
Price Target: $1,075 → $1,215
Current: $919.21
Upside: +32.18%
Biohaven
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $12.87
Upside: +133.10%
Codexis
Aug 17, 2026
Reiterated: Buy
Price Target: $9 → $8
Current: $1.36
Upside: +488.24%
Cogent Biosciences
Aug 17, 2026
Reiterated: Buy
Price Target: $52 → $55
Current: $31.02
Upside: +77.30%
Aug 17, 2026
Reiterated: Hold
Price Target: $1
Current: $0.5215
Upside: +91.75%
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $4.07
Upside: +194.84%
Aug 17, 2026
Reiterated: Buy
Price Target: $110 → $130
Current: $115.30
Upside: +12.75%
Aug 17, 2026
Reiterated: Buy
Price Target: $100 → $94
Current: $43.54
Upside: +115.89%
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $10.80
Upside: +177.91%
Aug 17, 2026
Reiterated: Buy
Price Target: $68
Current: $15.22
Upside: +346.78%
Aug 17, 2026
Reiterated: Hold
Price Target: $40 → $49
Current: $47.15
Upside: +3.92%
Aug 17, 2026
Reiterated: Buy
Price Target: $49 → $68
Current: $56.93
Upside: +19.44%
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $13.74
Upside: -12.66%
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $13.07
Upside: +7.12%
Jul 9, 2026
Rated: Buy
Price Target: $165 → $175
Current: $92.88
Upside: +88.42%
May 8, 2026
Downgraded: Hold
Price Target: $26 → $4
Current: $1.94
Upside: +106.19%
Jan 23, 2026
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.0002
Upside: +249,900.00%
Jul 18, 2024
Reiterated: Buy
Price Target: $22
Current: $35.72
Upside: n/a
Mar 14, 2024
Upgraded: Buy
Price Target: $8 → $20
Current: $6.85
Upside: n/a